Cancer Research UK

Cancer Research UK funds research across the entire cancer landscape, including work on causes, prevention, early detection, diagnosis, and treatment. They support discovery science, translational and clinical trials, biomarkers, immunotherapy, radiotherapy, drug discovery, and population health. The charity prioritises high-impact innovations across all cancer types and stages, including rare and aggressive cancers, as well as new treatments, diagnostics, and prevention strategies. They also fund capacity-building through fellowships and research consortia. Their funding is available to academic institutions, universities, NHS Trusts, and research centres across England, Scotland, Wales, and Northern Ireland.

This funder supports established research groups with a strong track record in oncology, rather than small charities or grassroots organisations. Eligible applicants include academic institutions, universities, NHS Trusts, and research centres based in the United Kingdom. There are no income thresholds, but applicants should be operating within a research-focused environment. The charity prioritises high-impact innovations and is suited to experienced researchers and clinicians leading substantial programmes of work. While unsolicited applications are generally welcome, the fit is best for those whose work aligns with the charity's scientific priorities.

Cancer Research UK does not fund non-research activities, unrestricted grants, or projects that are misaligned with their scientific focus. They are not suited to small charities, grassroots organisations, or groups without a clear oncology research track record. Funding is limited to research that directly contributes to understanding, preventing, diagnosing, or treating cancer, and does not extend to general community projects or fundraising activities.

Cancer Research UK supports a range of funding types, including project grants, programme grants, fellowships, and consortium awards, typically through a competitive and peer-reviewed process. They fund both one-off projects and longer-term programmes of work, depending on the scheme. The charity welcomes unsolicited applications and encourages informal discussions with their scientific team before submitting proposals. Their funding is characterised by a rigorous, evidence-based approach, with an emphasis on high-impact innovations for cancer outcomes.